🔎 Trials Near Me

Akèy › Maladi otoim › Kansas › Kansas City

Etid klinik pou Maladi otoim nan Kansas City, KS

6 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • University of Kansas Cancer Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • University of Kansas Medical Center - Accepting Adult Patients, Kansas City
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • University of Kansas Medical Center, Kansas City
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Ap rekriteFaz 1/2
  • University of Kansas Medical Center, Kansas City
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Ap rekriteFaz 2/3
  • University of Kansas Medical Center, Kansas City
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
  • University of Kansas Medical Center, Kansas City
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

Etid Maladi otoim nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.